Products 1796566-95-4

CAS 1796566-95-4 appears in our catalog under these names: Sacituzumab/ 95%, Sacituzumab, 98%, Sacituzumab, Sacituzumab, 99.9%, Sacituzumab (powder), 98.33%. Offered by: TargetMol, Chemat Brand, GLPBio, Biosynth, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, on request, 100mg, 1 mg.

Sacituzumab/ 95%
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 1222.97
View product
Sacituzumab, 98%
Chemat Brand
  • size: on request
  • Variants: 1
View product
Sacituzumab
GLPBio, Biosynth
  • size: 1mg, 10mg, 5mg, 100mg
  • Variants: 6
from 1172.74
View product
Sacituzumab, 99.9%
MedChemExpress
  • size: 1 mg, 100 mg, 50 mg, 10 mg
  • Variants: 6
from 1081.31
View product
Sacituzumab (powder), 98.33%
MedChemExpress
  • size: Get quote
  • Variants: 1
View product
Structural formula: {0} (CAS {1})

(2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-6-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid (CAS 1796566-95-4) is a chemical compound with the molecular formula C76H104N12O24S and a molecular weight of 1601.8 g/mol. IUPAC name: (2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-6-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid. InChIKey: ULRUOUDIQPERIJ-PQURJYPBSA-N.

Identity
Molecular formulaC76H104N12O24S
Molecular weight1601.8 g/mol
IUPAC name(2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-6-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid
InChIKeyULRUOUDIQPERIJ-PQURJYPBSA-N
SMILESCCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)OC(=O)OCC5=CC=C(C=C5)NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN6C=C(N=N6)CNC(=O)C7CCC(CC7)CN8C(=O)CC(C8=O)SC[C@@H](C(=O)O)N)C2=NC9=C1C=C(C=C9)O

Computed by PubChem (NCBI)

Synonyms: hRS7-SN38, Trodelvy, SacituzumabGovitecan, sacituzumabum govitecanum, Sacituzumab govitecan-hziy, hRS7SN38, hRS7-SN38 Antibody Drug Conjugate, Sacituzumab govitecan [USAN], hRS 7SN38, Satralizumab linker